Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 8, 2005, Pages 2954-2960

  Berkowitz, Bruce A ^a,b   Roberts, Robin ^a   Luan, Hongmei ^a   Peysakhov, Jamie ^a   Knoerzer, Deborah L ^c   Connor, Jane R ^c   Hohman, Thomas C ^d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c PFIZER INC   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LEVO N (6) (1 IMINOETHYL)LYSINE 5 TETRAZOLE AMIDE; STREPTOZOCIN; UNCLASSIFIED DRUG; CARBOGEN; CARBON DIOXIDE; DRUG DERIVATIVE; ENZYME INHIBITOR; LYSINE; N(6) (1 IMINOETHYL)LYSINE; N(6)-(1-IMINOETHYL)LYSINE; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; OXYGEN; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG EFFECT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HYPERGLYCEMIA; HYPEROXIA; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RAT; ANIMAL; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSURE; RETINA;

ANIMALS; BLOOD GLUCOSE; CARBON DIOXIDE; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENZYME INHIBITORS; LYSINE; MAGNETIC RESONANCE IMAGING; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OXYGEN; OXYGEN CONSUMPTION; PARTIAL PRESSURE; PYRAZOLES; RATS; RETINA; SULFONAMIDES;

EID: 24644454856     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0132     Document Type: Article

References (39)

1. Schmetterer L, Wolzt M. Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia. 1999;42:387-405.
2. Wangsa-Wirawan ND, Linsenmeier RA. Retinal oxygen: fundamental and clinical aspects. Arch Ophthalmol. 2003;121:547-557.
3. Yu DY, Cringle SJ, Alder VA, Su EN. Intraretinal oxygen distribution in rats as a function of systemic blood pressure. Am J Physiol. 1994;267:H2498-H2507.
4. Johnston AJ, Steine LA, Gupta AK, Menon DK. Cerebral oxygen vasoreactivity and cerebral tissue oxygen reactivity. Br J Anaesth. 2003;90:774-786.
5. 2 predicts therapeutic efficacy in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci. 2001;42:2964-2969.
6. Berkowitz BA, Kowluru RA, Frank RN, Kern TS, Hohman TC, Prakash M. Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2100-2105.
7. 2 mapping. Invest Ophthalmol Vis Sci. 1996;37:2089-2098.
8. Berkowitz BA, Wilson CA. Quantitative mapping of ocular oxygenation using magnetic resonance imaging. Magn Reson Meet. 1995; 33:579-581.
9. Berkowitz BA, McDonald C, Ito Y, Tofts PS, Latif Z, Gross J. Measuring the human retinal oxygenation response to a hyperoxic challenge using MRI: eliminating blinking artifacts and demonstrating proof of concept. Magn Reson Med. 2001;46:412-416.
10. Berkowitz BA, Luan H, Gupta RR, et al. Regulation of the early subnormal retinal oxygenation response in experimental diabetes by inducible nitric oxide synthase. Diabetes. 2004;53:173-178.
11. Robison WG Jr, Jacot JL, Glover JP, Basso MD, Hohman TC. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats. Invest Ophthalmol Vis Sci. 1998;39:1933-1941.
12. Hallinan EA, Tsymbalov S, Dorn CR, et al. Synthesis and biological characterization of L-N(6)-(1- iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor. J Med Chem. 2002;45:1686-1689.
13. Berkowitz BA. Role of dissolved plasma oxygen in hyperoxia-induced contrast. Magn Reson Imag. 1997;15:123-126.
14. Tofts PS, Berkowitz BA. Rapid measurement of capillary permeability using the early part of the dynamic Gd-DTPA MRI enhancement curve. J Magn Reson. 1993;102:129-136.
15. Ettl A, Fischer-Klein C, Chemelli A, Daxer A, Felber S. Proton relaxation times of the vitreous body in hereditary vitreoretinal dystrophy. Ophthalmologica. 1994;208:195-197.
16. Hopkins AL, Yeung HN, Bratton CB. Multiple field strength in vivo T1 and T2 for cerebrospinal fluid protons. Magn Reson Med. 1986;3:303-311.
17. Luoma K, Raininko R, Nummi P, Luukkonen R. Is the signal intensity of cerebrospinal fluid constant? - intensity measurements with high and low field magnetic resonance imagers. Magn Reson Imag. 1993;11:549-555.
18. Meyer ME, Yu O, Eclancher B, Grucker D, Chambron J. NMR relaxation rates and blood oxygenation level. Magn Reson Med. 1995;34:234-241.
19. Berkowitz BA, Zhang W. Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP. Invest Ophthalmol Vis Sci. 2000;41:1925-1931.
20. Alder VA, Yu DY, Cringle SJ. Vitreal oxygen tension measurements in the rat eye. Exp Eye Res. 1991;52:293-299.
21. Liang Z. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
22. Feise RJ. Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol. 2002;2:8.
23. Luan H, Leitges M, Gupta RR, et al. Effect of PKCbeta on retinal oxygenation response in experimental diabetes. Invest Ophthalmol Vis Sci. 2004;45:937-942.
24. Alder VA, Yu DY, Su EN, Cringle SJ. Comparison of hematologic parameters in normal and streptozotocin-induced diabetic rats. Lab Anim Sci. 1992;42:170-173.
25. Kanamori A, Nakamura M, Mukuno H, Maeda H, Negi A. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure. Curr Eye Res. 2004;28:47-54.
26. Yu DY, Cringle SJ, Alder V, Su EN. Intraretinal oxygen distribution in the rat with graded systemic hyperoxia and hypercapnia. Invest Ophthalmol Vis Sci. 1999;40:2082-2087.
27. Yu DY, Cringle SJ, Alder VA, Su EN, Yu PK. Intraretinal oxygen distribution and choroidal regulation in the avascular retina of guinea pigs. Am J Physiol. 1996;270:H965-H973.
28. 2. Invest Ophthalmol Vis Sci. 2004;45:3669-3677.
29. Pakola SJ, Grunwald JE. Effects of oxygen and carbon dioxide on human retinal circulation. Invest Ophthalmol Vis Sci. 1993;34:2866-2870.
30. Hickam JB, Frayser R. Studies of the retinal circulation in man: observation on vessel diameter, arteriovenous oxygen difference, and mean circulation time. Circulation 1966;32:302-316.
31. Sponsel WE, DePaul KL, Zetlan SR. Retinal hemodynamic effects of carbon dioxide, hyperoxia, and mild hypoxia. Invest Ophthalmol Vis Sci. 1992;33:1864-1869.
32. Haefliger IO, Lietz A, Griesser SM, et al. Modulation of Heidelberg Retinal Flowmeter parameter flow at the papilla of healthy subjects: effect of carbogen, oxygen, high intraocular pressure, and beta-blockers. Surv Ophthalmol. 1999;43(suppl 1):S59-S65.
33. Kadoi Y, Hinohara H, Kunimoto F, et al. Diabetic patients have an impaired cerebral vasodilatory response to hypercapnia under propofol anesthesia. Stroke. 2003;34:2399-2403.
34. Cosentino F, Eto M, De Paolis P, et al. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation. 2003;107:1017-1023.
35. Du Y, Smith MA, Miller CM, Kern TS. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem. 2002;80:771-779.
36. Kowluru RA, Kennedy A. Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opin Investig Drugs. 2001;10:1665-1676.
37. Vane JR, Mitchell JA, Appleton I, et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA. 1994:91:2046-2050.
38. Boje KM, Jaworowicz D Jr, Raybon JJ. Neuroinflammatory role of prostaglandins during experimental meningitis: evidence suggestive of an in vivo relationship between nitric oxide and prostaglandins. J. Pharmacol Exp Ther. 2003;304:319-325.
39. Kowluru RA, Chakrabarti S, Chen S. Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NF-kB) in the retina. Acta Diabetol. 2004;41:194-199.